Six cases of blood clotting with one fatality out of 7 million doses, less than one thousandth of a percent. All the patients are female and the rate of this rare disorder does not appear to be higher than those unvaccinated. The pause, just demonstrates how careful and cautious they are. It's the same situation with the AZ vaccine, almost all those afflicted were female and numbers indicate it is no more than would have it normally. These pauses are done out of an abundance of caution, compared to many over the counter medications, these vaccines are extremely safe.
---------------------------------------------------------------------------------------------------------------------------
Johnson & Johnson vaccine should be paused in U.S. after 'extremely rare' blood clots, FDA and CDC say (nbcnews.com)
Johnson & Johnson vaccine should be paused in U.S. after 'extremely rare' blood clots, FDA and CDC say
Some 6.8 million have received the vaccine in the United States. Of these six have experienced the clot, the FDA and CDC said.
Federal health agencies on Tuesday recommended pausing the use of
the Johnson & Johnson vaccine after a small number of people experienced "a rare and severe type of blood clot" after receiving the shot.
The Food and Drug Administration and the Centers for Disease Control and Prevention issued a statement saying they were "recommending a pause in the use of this vaccine out of an abundance of caution."
Some 6.8 million people have received
the single-shot vaccine in the United States. Of these, six have experienced the clot, the agencies said, adding: "Right now, these adverse events appear to be extremely rare."
The news was first reported by
The New York Times.
In a statement, Johnson & Johnson said it was aware that blood clots had been reported with some Covid-19 vaccines, but that "no clear causal relationship has been established between these rare events" and its shot.
"We continue to work closely with experts and regulators to assess the data and support the open communication of this information to healthcare professionals and the public," it said.
The six people who experienced clots were all women between the ages of 18 and 48, the FDA and CDC said. They had what's called a cerebral venous sinus thrombosis, or CVST, as well as low levels of blood platelets.
